Christopher Horan, Chief Technical Operations Officer, Artiva Biotherapeutics joins Cell & Gene: The Podcast Host, Erin Harris, to discuss the advantages natural killer (NK) cells have offer over T cells in terms of safety and efficacy for autoimmune disease. They take a deep dive into the key factors that make NK cells promising for ‘off-the-shelf’... The post Cell & Gene The Podcast: The Future of NK Cell Therapy for Autoimmune Disease appeared first on Artiva Biotherapeutics.
